Predominance of M1UK type strains and their clinical associations in invasive Streptococcus pyogenes infections in Japan, 2023–2025
Authors:
Open Access
- 31 August 2026
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- p. 1-11
Abstract
Purpose: The clinical relevance of M1 UK type strains of Streptococcus pyogenes in Japan remains insufficiently defined. We investigated the molecular epidemiology of M1 UK type strains and evaluated their clinical associations among adults with invasive group A Streptococcus (iGAS) infections. Methods: We conducted a nationwide multicenter surveillance study of iGAS infections from December 2023 to March 2025. Molecular typing, profiling of M1 UK -associated single-nucleotide polymorphisms (SNPs) in the rofA , gldA , and pstB regions, and emm -cluster assignment were performed. Adult clinical characteristics and outcomes were compared between M1 UK type and non-M1 type infections after exclusion of the single adult M1 global case. Results: Among 155 patients in the molecular epidemiology cohort, M1 UK type strains accounted for 58 isolates, whereas only one M1 global isolate was identified. Historical analysis showed that M1 global predominated among isolates collected in the early 2010s, whereas M1 UK type strains were detected mainly in recent periods. In adult clinical comparisons, M1 UK type infection was associated with streptococcal toxic shock syndrome (STSS; p = 0.004) and necrotizing fasciitis ( p < 0.001). In multivariable analysis, younger age, necrotizing fasciitis, and serum creatinine ≥ 2.0 mg/dL were associated with M1 UK type infection. Conclusion: M1 UK type strains were important contributors to contemporary iGAS infections in Japan and were associated with severe clinical presentations, supporting sustained molecular surveillance beyond conventional emm typing.Keywords
All Related Versions
This publication has 37 references indexed in Scilit:
- Global emergence and polycentric evolution of invasive Streptococcus pyogenes M1UK lineageJournal of Infection, 2025
- Additional biomarkers and emm types associated with group A streptococcal toxic shock syndrome: a Japanese nationwide observational studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2025
- Trends in the growing impact of group A Streptococcus infection on public health after COVID-19 pandemic: a multicentral observational study in Okayama, JapanEuropean Journal of Clinical Microbiology & Infectious Diseases, 2024
- Epidemiological shifts in and impact of COVID-19 on streptococcal toxic shock syndrome in Japan: A genotypic analysis of group A Streptococcus isolatesInternational Journal of Infectious Diseases, 2024
- Streptococcal protein SIC activates monocytes and induces inflammationiScience, 2021
- Molecular characterization and antimicrobial resistance of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2013 to 2018International Journal of Medical Microbiology, 2021
- Updated emm-typing protocol for Streptococcus pyogenesClinical Microbiology and Infection, 2020
- Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological studyThe Lancet Infectious Diseases, 2019
- Molecular evidence of new variant Brucella in North Pacific common minke whalesMicrobes and Infection, 2004
- Defining the Group A Streptococcal Toxic Shock SyndromeJAMA, 1993